Browse by category

ReShape has entered into an asset purchase agreement with Biorad Medisys, which is party to a previously disclosed exclusive license...

iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing...

The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...

Unjury Protein has launched its Protect & Restore Advanced Protein+ - the first clinically supported medical food and co-therapy for...

Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine balance for the...

The Scottish Medicines Consortium (SMC) has accepted Eli Lilly and Company’s tirzepatide (Mounjaro) for restricted use within NHS...

Asensus Surgical has entered into a definitive merger agreement with Karl Storz Endoscopy-America, a wholly owned direct subsidiary of...

Medtronic has announced the launch of new AI algorithms for post-operative analysis, providing AI surgical insights across laparoscopic...

Phenomix Sciences has launched a new MyPhenome test that now allows patients to test for all three identified phenotypes - Emotional...

Entera Bio has revealed positive pharmacokinetic results from its collaborative research combining a proprietary long acting GLP-2...